Stonepine Capital Management, LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 66Value: $102.8MLatest: 2025Q1

Stonepine Capital Management, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 66 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ENTA",
  "ACAD",
  "ANIP",
  "ADMA",
  "AMRN",
  "GLPG",
  "SLRN",
  "SVRA",
  "THRD",
  "ACET",
  "KROS",
  "ANIK",
  "APRE",
  "BIOA",
  "ESTA",
  "GERN",
  "CALC",
  "KALV",
  "MIST",
  "MYO",
  "NKTX",
  "PMVP",
  "RNXT",
  "SEPN",
  "TELA",
  null,
  "SRZN",
  "WHWK",
  "EDSA",
  "IOVA",
  "AYTU",
  null,
  "IKT",
  "ACRS",
  "ESPR",
  "HRTX",
  null,
  "AQST",
  "INDV.L",
  "SCPH",
  "PROF",
  "EBS",
  "EOLS",
  "XGN",
  null,
  "HLVX",
  "IMAB",
  "ITOS",
  "INO",
  "KZR",
  "URGN",
  "VNDA",
  "VSTM",
  "VIR",
  "XERS",
  "XOMA",
  null,
  "YMAB",
  "ZNTL",
  "ELAN",
  "OPTN",
  "CRGX",
  "CHRS",
  "COLL",
  "CRBP",
  "DAWN"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 66
Total Value: 102762727
Accession Number: 0000935836-25-000328
Form Type: 13F-HR
CIK: stonepine-capital-management
Manager Name: Stonepine-Capital-Management

Data Enrichment

92% identified

61 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

66 positions • $102.8M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 4

Sort by:

Evolus, Inc.

EOLS|30052C107

Shares:1.1M

Value:$13.6M

% of Portfolio:13.3% ($13.6M/$102.8M)

ANI PHARMACEUTICALS INC

ANIP|00182C103

Shares:48.0K

Value:$13.6M

% of Portfolio:13.3% ($13.6M/$102.8M)

OptiNose, Inc.

OPTN|68404V209

Shares:788.6K

Value:$7.2M

% of Portfolio:7.0% ($7.2M/$102.8M)

488445206

Shares:650.0K

Value:$4.9M

% of Portfolio:4.7% ($4.9M/$102.8M)

Verastem, Inc.

VSTM|92337C203

Shares:613.0K

Value:$3.7M

% of Portfolio:3.6% ($3.7M/$102.8M)

UroGen Pharma Ltd.

URGN|M96088105

Shares:333.4K

Value:$3.7M

% of Portfolio:3.6% ($3.7M/$102.8M)

Surrozen, Inc./DE

SRZN|86889P208

Shares:285.8K

Value:$3.3M

% of Portfolio:3.2% ($3.3M/$102.8M)

ENANTA PHARMACEUTICALS INC

ENTA|29251M106

Shares:590.7K

Value:$3.3M

% of Portfolio:3.2% ($3.3M/$102.8M)

Anika Therapeutics, Inc.

ANIK|035255108

Shares:206.6K

Value:$3.3M

% of Portfolio:3.2% ($3.3M/$102.8M)

ESTABLISHMENT LABS HOLDINGS INC.

ESTA|G31249108

Shares:74.5K

Value:$3.0M

% of Portfolio:3.0% ($3.0M/$102.8M)

Aquestive Therapeutics, Inc.

AQST|03843E104

Shares:200.0K

Value:$3.0M

% of Portfolio:3.0% ($3.0M/$102.8M)

INDIVIOR PLC

INDV.L|G4766E116

Shares:304.0K

Value:$2.9M

% of Portfolio:2.8% ($2.9M/$102.8M)

Day One Biopharmaceuticals, Inc.

DAWN|23954D109

Shares:348.8K

Value:$2.8M

% of Portfolio:2.7% ($2.8M/$102.8M)

Aclaris Therapeutics, Inc.

ACRS|00461U105

Shares:527.8K

Value:$2.8M

% of Portfolio:2.7% ($2.8M/$102.8M)

XOMA Royalty Corp

XOMA|98419J206

Shares:129.8K

Value:$2.6M

% of Portfolio:2.5% ($2.6M/$102.8M)

TELA Bio, Inc.

TELA|872381108

Shares:2.1M

Value:$2.5M

% of Portfolio:2.4% ($2.5M/$102.8M)

GALAPAGOS NV

GLPG|36315X101

Shares:94.0K

Value:$2.4M

% of Portfolio:2.3% ($2.4M/$102.8M)

Inhibikase Therapeutics, Inc.

IKT|45719W205

Shares:915.0K

Value:$2.0M

% of Portfolio:1.9% ($2.0M/$102.8M)

HERON THERAPEUTICS, INC. /DE/

HRTX|427746102

Shares:796.1K

Value:$1.8M

% of Portfolio:1.7% ($1.8M/$102.8M)

Edesa Biotech, Inc.

EDSA|27966L306

Shares:687.5K

Value:$1.7M

% of Portfolio:1.6% ($1.7M/$102.8M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Evolus, Inc.(EOLScusip30052C107)	1.1M	QoQ -10.28% (-130.1K) YoY -57.57% (-1.5M)	All Managers (Combined)	$13.6M	13.3% ($13.6M/$102.8M)	QoQ -2.24% (-$312.8K) YoY -63.54% (-$23.8M)
ANI PHARMACEUTICALS INC(ANIPcusip00182C103)	48.0K	QoQ +135.29% (+27.6K) YoY NEW(+48.0K)	All Managers (Combined)	$13.6M	13.3% ($13.6M/$102.8M)	QoQ +1110.32% (+$12.5M) YoY NEW(+$13.6M)
OptiNose, Inc.(OPTNcusip68404V209)	788.6K	QoQ +33.97% (+200.0K) YoY NEW(+788.6K)	All Managers (Combined)	$7.2M	7.0% ($7.2M/$102.8M)	QoQ +83.91% (+$3.3M) YoY NEW(+$7.2M)
(cusip488445206)✕	650.0K	QoQ +8.75% (-52.3K) YoY NEW(+650.0K)	All Managers (Combined)	$4.9M	4.7% ($4.9M/$102.8M)	QoQ -2.33% (-$116.3K) YoY NEW(+$4.9M)
Verastem, Inc.(VSTMcusip92337C203)	613.0K	QoQ -29.54% (-257.0K) YoY NEW(+613.0K)	All Managers (Combined)	$3.7M	3.6% ($3.7M/$102.8M)	QoQ -17.81% (-$801.5K) YoY NEW(+$3.7M)
UroGen Pharma Ltd.(URGNcusipM96088105)	333.4K	QoQ +2.79% (+9.1K) YoY NEW(+333.4K)	All Managers (Combined)	$3.7M	3.6% ($3.7M/$102.8M)	QoQ +6.75% (+$233.4K) YoY NEW(+$3.7M)
Surrozen, Inc./DE(SRZNcusip86889P208)	285.8K	QoQ +108.29% (+148.6K) YoY NEW(+285.8K)	All Managers (Combined)	$3.3M	3.2% ($3.3M/$102.8M)	QoQ +69.24% (+$1.4M) YoY NEW(+$3.3M)
ENANTA PHARMACEUTICALS INC(ENTAcusip29251M106)	590.7K	QoQ +77.98% (+258.8K) YoY NEW(+590.7K)	All Managers (Combined)	$3.3M	3.2% ($3.3M/$102.8M)	QoQ +70.86% (+$1.4M) YoY NEW(+$3.3M)
Anika Therapeutics, Inc.(ANIKcusip035255108)	206.6K	QoQ -13.25% (-31.6K) YoY +239.03% (+145.7K)	All Managers (Combined)	$3.3M	3.2% ($3.3M/$102.8M)	QoQ -16.83% (-$660.2K) YoY +110.63% (+$1.7M)
ESTABLISHMENT LABS HOLDINGS INC.(ESTAcusipG31249108)	74.5K	QoQ -6.87% (-5.5K) YoY NEW(+74.5K)	All Managers (Combined)	$3.0M	3.0% ($3.0M/$102.8M)	QoQ -17.51% (-$645.7K) YoY NEW(+$3.0M)
Aquestive Therapeutics, Inc.(AQSTcusip03843E104)	200.0K	QoQ +25.00% (+40.0K) YoY NEW(+200.0K)	All Managers (Combined)	$3.0M	3.0% ($3.0M/$102.8M)	QoQ +433.70% (+$2.5M) YoY NEW(+$3.0M)
INDIVIOR PLC(INDV.LcusipG4766E116)	304.0K	QoQ -0.32% (-1.0K) YoY NEW(+304.0K)	All Managers (Combined)	$2.9M	2.8% ($2.9M/$102.8M)	QoQ -23.58% (-$894.0K) YoY NEW(+$2.9M)
Day One Biopharmaceuticals, Inc.(DAWNcusip23954D109)	348.8K	QoQ +48.43% (-113.8K) YoY NEW(+348.8K)	All Managers (Combined)	$2.8M	2.7% ($2.8M/$102.8M)	QoQ -7.09% (-$211.3K) YoY NEW(+$2.8M)
Aclaris Therapeutics, Inc.(ACRScusip00461U105)	527.8K	QoQ -20.43% (-135.6K) YoY NEW(+527.8K)	All Managers (Combined)	$2.8M	2.7% ($2.8M/$102.8M)	QoQ +68.12% (-$1.1M) YoY NEW(+$2.8M)
XOMA Royalty Corp(XOMAcusip98419J206)	129.8K	QoQ +3.27% (-4.1K) YoY -48.84% (-124.0K)	All Managers (Combined)	$2.6M	2.5% ($2.6M/$102.8M)	QoQ -21.68% (-$716.2K) YoY -57.60% (-$3.5M)
TELA Bio, Inc.(TELAcusip872381108)	2.1M	QoQ -12.65% (-297.9K) YoY +198.63% (-1.4M)	All Managers (Combined)	$2.5M	2.4% ($2.5M/$102.8M)	QoQ -64.71% (-$4.6M) YoY -35.74% (-$1.4M)
GALAPAGOS NV(GLPGcusip36315X101)	94.0K	QoQ -53.01% (-106.0K) YoY -76.12% (-299.7K)	All Managers (Combined)	$2.4M	2.3% ($2.4M/$102.8M)	QoQ -57.08% (-$3.1M) YoY -81.37% (-$10.3M)
Inhibikase Therapeutics, Inc.(IKTcusip45719W205)	915.0K	QoQ -19.19% (-217.4K) YoY NEW(+915.0K)	All Managers (Combined)	$2.0M	1.9% ($2.0M/$102.8M)	QoQ -45.55% (-$1.7M) YoY NEW(+$2.0M)
HERON THERAPEUTICS, INC. /DE/(HRTXcusip427746102)	796.1K	QoQ +13.72% (+96.1K) YoY NEW(+796.1K)	All Managers (Combined)	$1.8M	1.7% ($1.8M/$102.8M)	QoQ +63.53% (+$680.4K) YoY NEW(+$1.8M)
Edesa Biotech, Inc.(EDSAcusip27966L306)	687.5K	QoQ NEW(+687.5K) YoY NEW(+687.5K)	All Managers (Combined)	$1.7M	1.6% ($1.7M/$102.8M)	QoQ NEW(+$1.7M) YoY NEW(+$1.7M)